| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/16/2008 | CN101219169A Externally used Chinese medicine for treating prostate gland hyperplasia and delaying human body caducity |
| 07/16/2008 | CN101219151A Bicarbonate-based solutions for dialysis therapies |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | CA2425560C Anticholinergics, processes for preparing them and their use as pharmaceutical compositions |
| 07/15/2008 | CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2144185C Method of prophylaxis of acute renal failure |
| 07/10/2008 | WO2008080924A1 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors |
| 07/10/2008 | WO2008061247A3 Benzenesulfonanilide compound inhibitors of urea transporters |
| 07/10/2008 | WO2008040774A3 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 07/10/2008 | WO2007149366B1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080167382 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 07/10/2008 | US20080167367 Stable hydrate of a muscarinic receptor antagonist |
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167317 Combination Therapy |
| 07/10/2008 | US20080167303 Aryl sulfamide derivatives and methods of their use |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080166402 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166370 Immunogenic Compositions Comprising Multiple Gonococcal Antigens |
| 07/10/2008 | CA2674162A1 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942106A1 Therapeutic agents useful for treating pain |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1940470A2 Antibody-drug conjugates and methods of use |
| 07/09/2008 | EP1841316A4 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases |
| 07/09/2008 | EP1715890B1 Ctgf as target for the therapy of microalbuminuria in patients with diabetic nephropathy |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | EP0959878B1 Method for treating renal failure |
| 07/09/2008 | CN101217960A Therapeutic agent and treatment method for ameliorating uremia |
| 07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
| 07/09/2008 | CN101214357A Pharmaceutical composition for treating chronic prostatitis |
| 07/09/2008 | CN101214316A Nicandra physaloides cultivated in north decocted in water (simple prescription) capable of treating chronic kidney disease |
| 07/09/2008 | CN101214300A Medicament for treating prostate gland disease and preparation thereof |
| 07/09/2008 | CN101214276A Plant medicine for treating BPH with cassia twig (or cinnamon) as raw material |
| 07/09/2008 | CN101214266A Paecilomyces hepiali mycelium mixed powder and preparation |
| 07/09/2008 | CN101214105A Chinese herbal medicine health care cushion and preparation thereof |
| 07/09/2008 | CN100400547C Human monoclonal antibodies to prostate specific membrane antigen |
| 07/09/2008 | CN100400065C Nutritional oral liquid for health care and preparation method |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/08/2008 | CA2187444C Antirestenosis protein |
| 07/03/2008 | WO2008078728A1 Ascorbic acid-containing pharmaceutical composition |
| 07/03/2008 | WO2008078727A1 Pharmaceutical composition having improved dissolution property |
| 07/03/2008 | WO2008078726A1 Solid preparation |
| 07/03/2008 | WO2008077916A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/03/2008 | WO2008077599A1 COMBINATION THERAPY OF LOWER URINARY TRACT DISORDERS WITH α2δ LIGANDS AND NSAIDS |
| 07/03/2008 | WO2008051977A3 Methods of reducing phosphate absorption |
| 07/03/2008 | WO2008041184A3 Muscarinic receptor antagonists |
| 07/03/2008 | WO2008034796A3 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161337 Use of Rifaximin for the Treatment of Chronic Prostatitis |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161309 Novel Compounds |
| 07/03/2008 | US20080161297 Rho kinase inhibitors |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080160060 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | CA2673545A1 Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids |
| 07/03/2008 | CA2673391A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939194A1 Bicyclic aromatic substituted pyridone derivative |
| 07/02/2008 | EP1939183A1 Novel nitrogenated heterocyclic compound |
| 07/02/2008 | EP1938813A1 Agent for reduction of oxidized albumin level |
| 07/02/2008 | EP1938812A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/02/2008 | EP1937669A1 Novel benzopyran derivatives as potassium channel openers |
| 07/02/2008 | EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof |
| 07/02/2008 | EP1937264A2 Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |